{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:35:28Z","timestamp":1792784128173,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T00:00:00Z","timestamp":1682380800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T00:00:00Z","timestamp":1682380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"KWF Kankerbestrijding\/Stichting Alpe d\u2019HuZes","award":["BMA 5954"],"award-info":[{"award-number":["BMA 5954"]}],"id":[{"id":"https:\/\/ror.org\/0368jnd28","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Surviv"],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>The aim of this study is to assess cost-effectiveness of general practitioner (GP) versus surgeon-led colon cancer survivorship care from a societal perspective.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed an economic evaluation alongside the I CARE study, which included 303 cancer patients (stages I\u2013III) who were randomised to survivorship care by a GP or surgeon. Questionnaires were administered at baseline, 3-, 6-, 12-, 24- and 36-months. Costs included healthcare costs (measured by iMTA MCQ) and lost productivity costs (SF-HLQ). Disease-specific quality of life (QoL) was measured using EORTC QLQ-C30 summary score and general QoL using EQ-5D-3L quality-adjusted life years (QALYs). Missing data were imputed. Incremental cost-effectiveness ratios (ICERs) were calculated to relate costs to effects on QoL. Statistical uncertainty was estimated using bootstrapping.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Total societal costs of GP-led care were significantly lower compared to surgeon-led care (mean difference of\u2009\u2212\u2009\u20ac3895; 95% CI\u2009\u2212\u2009\u20ac6113;\u2009\u2212\u2009\u20ac1712). Lost productivity was the main contributor to the difference in societal costs (\u2212\u2009\u20ac3305; 95% CI\u2009\u2212\u2009\u20ac5028;\u2009\u2212\u2009\u20ac1739). The difference in QLQ-C30 summary score over time between groups was 1.33 (95% CI\u2009\u2212\u20090.049; 3.15). The ICER for QLQ-C30 was\u2009\u2212\u20092073, indicating that GP-led care is dominant over surgeon-led care. The difference in QALYs was\u2009\u2212\u20090.021 (95% CI\u2009\u2212\u20090.083; 0.040) resulting in an ICER of 129,164.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>GP-led care is likely to be cost-effective for disease-specific QoL, but not for general QoL.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Implications for cancer survivors<\/jats:title>\n                    <jats:p>With a growing number of cancer survivors, GP-led survivorship care could help to alleviate some of the burden on more expensive secondary healthcare services.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11764-023-01383-4","type":"journal-article","created":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T05:02:43Z","timestamp":1682398963000},"page":"1393-1402","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Cost-effectiveness of general practitioner- versus surgeon-led colon cancer survivorship care: an economic evaluation alongside a randomised controlled trial"],"prefix":"10.1007","volume":"18","author":[{"given":"Julien A. M.","family":"Vos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"El Alili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura A. M.","family":"Duineveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thijs","family":"Wieldraaijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Wind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edanur","family":"Sert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra C.","family":"Donkervoort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc J. P. M.","family":"Govaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanette A. W.","family":"van Geloven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony W. H.","family":"van de Ven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gijsbert","family":"Heuff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henk C. P. M.","family":"van Weert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith E.","family":"Bosmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristel M.","family":"van Asselt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the ICARE study group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,25]]},"reference":[{"issue":"4","key":"1383_CR1","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1136\/gutjnl-2015-310912","volume":"66","author":"M Arnold","year":"2017","unstructured":"Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017;66(4):683\u201391.","journal-title":"Gut"},{"key":"1383_CR2","volume-title":"From cancer patient to cancer survivor: lost in transition","author":"M Hewitt","year":"2006","unstructured":"Hewitt M, Greenfield S, Stovall E. From cancer patient to cancer survivor: lost in transition. Washington, DC: National Academies Press; 2006."},{"issue":"9","key":"1383_CR3","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.6004\/jnccn.2020.7568","volume":"18","author":"SM Qaderi","year":"2020","unstructured":"Qaderi SM, Dickman PW, de Wilt JHW, Verhoeven RHA. Conditional survival and cure of patients with colon or rectal cancer: a population-based study. J Natl Compr Canc Netw. 2020;18(9):1230\u20137.","journal-title":"J Natl Compr Canc Netw"},{"key":"1383_CR4","unstructured":"The Dutch Ministry of Health, Welfare and Sports (VWS) [Internet]. Accessed 11th of May 2022. [Available from: https:\/\/www.vzinfo.nl\/dikkedarmkanker\/zorguitgaven]."},{"key":"1383_CR5","volume-title":"Costing manual: methodology of costing research and reference prices for economic evaluations in healthcare","author":"L Hakkaart-van Roijen","year":"2016","unstructured":"Hakkaart-van Roijen L, Van der Linden N, Bouwmans CAM, et al. Costing manual: methodology of costing research and reference prices for economic evaluations in healthcare. Diemen: Dutch Healthcare Institute; 2016."},{"issue":"2","key":"1383_CR6","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3109\/02813432.2014.929811","volume":"32","author":"D Brandenbarg","year":"2014","unstructured":"Brandenbarg D, Roorda C, Groenhof F, Havenga K, Berger MY, de Bock GH, et al. Increased primary health care use in the first year after colorectal cancer diagnosis. Scand J Prim Health Care. 2014;32(2):55\u201361.","journal-title":"Scand J Prim Health Care"},{"issue":"33","key":"1383_CR7","doi-asserted-by":"publisher","first-page":"4155","DOI":"10.1200\/JCO.2012.41.9101","volume":"30","author":"M Heins","year":"2012","unstructured":"Heins M, Schellevis F, Rijken M, van der Hoek L, Korevaar J. Determinants of increased primary health care use in cancer survivors. J Clin Oncol. 2012;30(33):4155\u201360.","journal-title":"J Clin Oncol"},{"issue":"1","key":"1383_CR8","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrclinonc.2013.212","volume":"11","author":"JD Emery","year":"2014","unstructured":"Emery JD, Shaw K, Williams B, Mazza D, Fallon-Ferguson J, Varlow M, et al. The role of primary care in early detection and follow-up of cancer. Nat Rev Clin Oncol. 2014;11(1):38\u201348.","journal-title":"Nat Rev Clin Oncol"},{"key":"1383_CR9","unstructured":"Health Council of the Netherlands. Follow-up in oncology\u2014identify objectives, substantiate actions. 2007; publication no. 2007\/10."},{"issue":"1","key":"1383_CR10","doi-asserted-by":"publisher","first-page":"bjgpopen20X1011","DOI":"10.3399\/bjgpopen20X101124","volume":"5","author":"EA Noteboom","year":"2021","unstructured":"Noteboom EA, Perfors IA, May AM, Stegmann ME, Duijts SF, Visserman EA, et al. GP involvement after a cancer diagnosis; patients\u2019 call to improve decision support. BJGP Open. 2021;5(1):bjgpopen20X101124.","journal-title":"BJGP Open"},{"issue":"1","key":"1383_CR11","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s11764-020-00911-w","volume":"15","author":"JAM Vos","year":"2020","unstructured":"Vos JAM, Wieldraaijer T, van Weert H, van Asselt KM. Survivorship care for cancer patients in primary versus secondary care: a systematic review. J Cancer Surviv. 2020;15(1):66\u201376.","journal-title":"J Cancer Surviv."},{"issue":"11","key":"1383_CR12","first-page":"425","volume":"2019","author":"BL Hoeg","year":"2019","unstructured":"Hoeg BL, Bidstrup PE, Karlsen RV, Friberg AS, Albieri V, Dalton SO, et al. Follow-up strategies following completion of primary cancer treatment in adult cancer survivors. Cochrane Database Syst Rev. 2019;2019(11):425.","journal-title":"Cochrane Database Syst Rev"},{"key":"1383_CR13","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/s13063-015-0798-7","volume":"16","author":"LA Duineveld","year":"2015","unstructured":"Duineveld LA, Wieldraaijer T, van Asselt KM, Nugteren IC, Donkervoort SC, van de Ven AW, et al. Improving care after colon cancer treatment in The Netherlands, personalised care to enhance quality of life (I CARE study): study protocol for a randomised controlled trial. Trials. 2015;16:284.","journal-title":"Trials"},{"issue":"8","key":"1383_CR14","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/S1470-2045(21)00273-4","volume":"22","author":"JAM Vos","year":"2021","unstructured":"Vos JAM, Duineveld LAM, Wieldraaijer T, Wind J, Busschers WB, Sert E, et al. Effect of general practitioner-led versus surgeon-led colon cancer survivorship care, with or without eHealth support, on quality of life (I CARE): an interim analysis of 1-year results of a randomised, controlled trial. Lancet Oncol. 2021;22(8):1175\u201387.","journal-title":"Lancet Oncol"},{"issue":"10334","key":"1383_CR15","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1016\/S0140-6736(22)00306-3","volume":"399","author":"M Jefford","year":"2022","unstructured":"Jefford M, Howell D, Li Q, Lisy K, Maher J, Alfano CM, et al. Improved models of care for cancer survivors. The Lancet. 2022;399(10334):1551\u201360.","journal-title":"The Lancet"},{"issue":"8","key":"1383_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-048985","volume":"11","author":"LAM Duineveld","year":"2021","unstructured":"Duineveld LAM, Vos JAM, Wieldraaijer T, Donkervoort SC, Wind J, van Weert H, et al. Recruitment challenges to the I CARE study: a randomised trial on general practitioner-led colon cancer survivorship care. BMJ Open. 2021;11(8): e048985.","journal-title":"BMJ Open"},{"key":"1383_CR17","unstructured":"National Guideline Colorectal Carcinoma (CRC) [Internet]. Available from: https:\/\/www.oncoline.nl\/colorectaalcarcinoom [Accessed 10th of June 2020]."},{"key":"1383_CR18","unstructured":"Castor EDC. Castor Electronic Data Capture 2019 [Internet]. Available from: https:\/\/www.castoredc.com [Accessed 27th of August 2019]."},{"issue":"11","key":"1383_CR19","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1007\/s00384-021-03914-w","volume":"36","author":"SM Qaderi","year":"2021","unstructured":"Qaderi SM, Galjart B, Verhoef C, Slooter GD, Koopman M, Verhoeven RHA, et al. Disease recurrence after colorectal cancer surgery in the modern era: a population-based study. Int J Colorectal Dis. 2021;36(11):2399\u2013410.","journal-title":"Int J Colorectal Dis"},{"issue":"5","key":"1383_CR20","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","volume":"85","author":"NK Aaronson","year":"1993","unstructured":"Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365\u201376.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"1383_CR21","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0168-8510(96)00822-6","volume":"37","author":"R Brooks","year":"1996","unstructured":"Brooks R. EuroQol: the current state of play. Health Policy. 1996;37(1):53\u201372.","journal-title":"Health Policy"},{"key":"1383_CR22","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jclinepi.2015.08.007","volume":"69","author":"JM Giesinger","year":"2016","unstructured":"Giesinger JM, Kieffer JM, Fayers PM, Groenvold M, Petersen MA, Scott NW, et al. Replication and validation of higher order models demonstrated that a summary score for the EORTC QLQ-C30 is robust. J Clin Epidemiol. 2016;69:79\u201388.","journal-title":"J Clin Epidemiol"},{"issue":"28","key":"1383_CR23","first-page":"1574","volume":"149","author":"LM Lamers","year":"2005","unstructured":"Lamers LM, Stalmeier PF, McDonnell J, Krabbe PF, van Busschbach JJ. Measuring the quality of life in economic evaluations: the Dutch EQ-5D tariff. Ned Tijdschr Geneeskd. 2005;149(28):1574\u20138.","journal-title":"Ned Tijdschr Geneeskd"},{"key":"1383_CR24","unstructured":"iMTA Productivity and Health Research Group. Manual iMTA Medical Cost Questionnaire (iMCQ) [Internet]. Available from: https:\/\/www.imta.nl\/questionnaires\/imcq\/publications\/ [Accessed 15th of May 2022]."},{"key":"1383_CR25","unstructured":"The Dutch Ministry of Health, Welfare and Sports (VWS) - Dutch Healthcare Institute [Internet]. Available from: https:\/\/www.medicijnkosten.nl\/zoeken [Accessed 18th of May 2022]."},{"issue":"3","key":"1383_CR26","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1017\/S0266462300009764","volume":"12","author":"L van Roijen","year":"1996","unstructured":"van Roijen L, Essink-Bot ML, Koopmanschap MA, Bonsel G, Rutten FF. Labor and health status in economic evaluation of health care. The Health and Labor Questionnaire. Int J Technol Assess Health Care. 1996;12(3):405\u201315.","journal-title":"Int J Technol Assess Health Care."},{"issue":"3","key":"1383_CR27","doi-asserted-by":"publisher","first-page":"67","DOI":"10.18637\/jss.v045.i03","volume":"45","author":"S van Buuren","year":"2011","unstructured":"van Buuren S, Groothuis-Oudshoorn K. Mice: multivariate imputation by chained equations in R. 2011. J Stat Softw. 2011;45(3):67.","journal-title":"J Stat Softw"},{"issue":"12","key":"1383_CR28","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1007\/s40273-014-0193-3","volume":"32","author":"R Faria","year":"2014","unstructured":"Faria R, Gomes M, Epstein D, White IR. A guide to handling missing data in cost-effectiveness analysis conducted within randomised controlled trials. Pharmacoeconomics. 2014;32(12):1157\u201370.","journal-title":"Pharmacoeconomics"},{"issue":"4","key":"1383_CR29","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/sim.4067","volume":"30","author":"IR White","year":"2011","unstructured":"White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med. 2011;30(4):377\u201399.","journal-title":"Stat Med"},{"key":"1383_CR30","doi-asserted-by":"crossref","unstructured":"Rubin DB. Multiple imputation for nonresponse in surveys.\u00a0Wiley, New York; 1987.  p. xxix, 258.","DOI":"10.1002\/9780470316696"},{"issue":"11","key":"1383_CR31","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1007\/s40273-020-00946-y","volume":"38","author":"M El Alili","year":"2020","unstructured":"El Alili M, van Dongen JM, Goldfeld KS, Heymans MW, van Tulder MW, Bosmans JE. Taking the analysis of trial-based economic evaluations to the next level: the importance of accounting for clustering. Pharmacoeconomics. 2020;38(11):1247\u201361.","journal-title":"Pharmacoeconomics"},{"key":"1383_CR32","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9780511610806","volume-title":"Applied multilevel analysis: a practical guide for medical researchers","author":"JW Twisk","year":"2006","unstructured":"Twisk JW. Applied multilevel analysis: a practical guide for medical researchers. Cambridge University Press; 2006."},{"key":"1383_CR33","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9781139342834","volume-title":"Applied longitudinal data analysis for epidemiology: a practical guide","author":"JW Twisk","year":"2013","unstructured":"Twisk JW. Applied longitudinal data analysis for epidemiology: a practical guide. Cambridge University Press; 2013."},{"key":"1383_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-81865-4","volume-title":"Analysis of data from randomized controlled trials. A practical guide Cham","author":"JW Twisk","year":"2021","unstructured":"Twisk JW. Analysis of data from randomized controlled trials. A practical guide Cham. Springer; 2021."},{"issue":"5","key":"1383_CR35","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/hec.944","volume":"14","author":"A Manca","year":"2005","unstructured":"Manca A, Hawkins N, Sculpher MJ. Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility. Health Econ. 2005;14(5):487\u201396.","journal-title":"Health Econ"},{"issue":"5","key":"1383_CR36","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1002\/hec.903","volume":"13","author":"E Fenwick","year":"2004","unstructured":"Fenwick E, O\u2019Brien BJ, Briggs A. Cost-effectiveness acceptability curves\u2014facts, fallacies and frequently asked questions. Health Econ. 2004;13(5):405\u201315.","journal-title":"Health Econ"},{"issue":"4","key":"1383_CR37","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1097\/JOM.0000000000000130","volume":"56","author":"JS Hoch","year":"2014","unstructured":"Hoch JS, Dewa CS. Advantages of the net benefit regression framework for economic evaluations of interventions in the workplace: a case study of the cost-effectiveness of a collaborative mental health care program for people receiving short-term disability benefits for psychiatric disorders. J Occup Environ Med. 2014;56(4):441\u20135.","journal-title":"J Occup Environ Med"},{"issue":"9","key":"1383_CR38","doi-asserted-by":"publisher","first-page":"A671","DOI":"10.1016\/j.jval.2017.08.1645","volume":"20","author":"AW Karpenko","year":"2017","unstructured":"Karpenko AW, Geenen JW, Vreman RA, Hovels A. The introduction of a threshold for the icer and the implications for reimbursement of drugs in the Dutch healthcare system. Value in Health. 2017;20(9):A671.","journal-title":"Value in Health"},{"issue":"4","key":"1383_CR39","doi-asserted-by":"publisher","first-page":"e002391","DOI":"10.1136\/bmjopen-2012-002391","volume":"3","author":"KM Augestad","year":"2013","unstructured":"Augestad KM, Norum J, Dehof S, Aspevik R, Ringberg U, Nestvold T, et al. Cost-effectiveness and quality of life in surgeon versus general practitioner-organised colon cancer surveillance: a randomised controlled trial. BMJ Open. 2013;3(4):e002391.","journal-title":"BMJ Open"},{"issue":"7\u20138","key":"1383_CR40","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1038\/sj.bjc.6690197","volume":"79","author":"E Grunfeld","year":"1999","unstructured":"Grunfeld E, Gray A, Mant D, Yudkin P, Adewuyi-Dalton R, Coyle D, et al. Follow-up of breast cancer in primary care vs specialist care: results of an economic evaluation. Br J Cancer. 1999;79(7\u20138):1227\u201333.","journal-title":"Br J Cancer"},{"key":"1383_CR41","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/1477-7525-5-70","volume":"5","author":"AS Pickard","year":"2007","unstructured":"Pickard AS, Neary MP, Cella D. Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer. Health Qual Life Outcomes. 2007;5:70.","journal-title":"Health Qual Life Outcomes"},{"issue":"1","key":"1383_CR42","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jval.2017.09.004","volume":"21","author":"M Hernandez Alava","year":"2018","unstructured":"Hernandez Alava M, Wailoo A, Grimm S, Pudney S, Gomes M, Sadique Z, et al. EQ-5D-5L versus EQ-5D-3L: the impact on cost effectiveness in the United Kingdom. Value Health. 2018;21(1):49\u201356.","journal-title":"Value Health"},{"issue":"1","key":"1383_CR43","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12875-021-01610-w","volume":"23","author":"JAM Vos","year":"2022","unstructured":"Vos JAM, de Best R, Duineveld LAM, van Weert HCPM, van Asselt KM. Delivering colon cancer survivorship care in primary care; a qualitative study on the experiences of general practitioners. BMC Primary Care. 2022;23(1):13.","journal-title":"BMC Primary Care"},{"issue":"727","key":"1383_CR44","doi-asserted-by":"publisher","first-page":"e115","DOI":"10.3399\/BJGP.2022.0104","volume":"73","author":"JA Vos","year":"2023","unstructured":"Vos JA, van Miltenburg VE, Beverdam FH, van Weert HC, van Asselt KM. Patient experiences of GP-led colon cancer survivorship care: a Dutch mixed-methods evaluation. Br J Gen Pract. 2023;73(727):e115\u201323.","journal-title":"Br J Gen Pract"},{"key":"1383_CR45","doi-asserted-by":"publisher","unstructured":"Vos JAM, Sert E, Busschers WB, Duineveld LAM, Wieldraaijer T, Wind J, et al. Detection of colon cancer recurrences during follow-up care by general practitioners versus surgeons. J Natl Cancer Inst. 2023. https:\/\/doi.org\/10.1093\/jnci\/djad019","DOI":"10.1093\/jnci\/djad019"},{"issue":"8","key":"1383_CR46","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1038\/sj.bjc.6603052","volume":"94","author":"DA Wattchow","year":"2006","unstructured":"Wattchow DA, Weller DP, Esterman A, Pilotto LS, McGorm K, Hammett Z, et al. General practice vs surgical-based follow-up for patients with colon cancer: randomised controlled trial. Br J Cancer. 2006;94(8):1116\u201321.","journal-title":"Br J Cancer"}],"container-title":["Journal of Cancer Survivorship"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-023-01383-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11764-023-01383-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-023-01383-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T05:26:37Z","timestamp":1723613197000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11764-023-01383-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,25]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["1383"],"URL":"https:\/\/doi.org\/10.1007\/s11764-023-01383-4","relation":{},"ISSN":["1932-2259","1932-2267"],"issn-type":[{"value":"1932-2259","type":"print"},{"value":"1932-2267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,25]]},"assertion":[{"value":"9 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the medical ethics committee of the Academic Medical Centre (Amsterdam, The Netherlands) (MEC 2014_332). The study was conducted according to the principles of Good Clinical Practice. Written informed consent for data collection was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}